相似文献
1
[Workshop on fatigue and multiple sclerosis].
Rev Neurol (Paris). 2000 Nov;156(11):1057-8.
2
Dalfampridine (Ampyra) for MS.
Med Lett Drugs Ther. 2010 Sep 20;52(1347):73-4.
3
[Relationship between fatigue in multiple sclerosis and the chronic fatigue syndrome].
Rev Neurol (Paris). 2000 Nov;156(11):1044-5.
4
Fatigue in multiple sclerosis: a diagnostic and therapeutic challenge.
Expert Opin Pharmacother. 2012 Apr;13(6):791-3. doi: 10.1517/14656566.2012.667075. Epub 2012 Mar 19.
5
[Perspectives on managing patients with fatigue].
Rev Neurol (Paris). 2000 Nov;156(11):1046-7.
6
Dalfampridine (Ampyra) for multiple sclerosis.
Nurse Pract. 2010 Nov;35(11):7-9. doi: 10.1097/01.NPR.0000389051.00652.80.
7
Sustained release oral fampridine in the treatment of multiple sclerosis.
Expert Opin Pharmacother. 2009 Aug;10(12):2025-35. doi: 10.1517/14656560903075994.
8
[Fampyra for multiple sclerosis].
Perspect Infirm. 2012 Sep-Oct;9(5):67.
9
[Analysis of subjective complaints of fatigue in patients with multiple sclerosis].
Rev Neurol (Paris). 2000 Nov;156(11):1048-50.
10
4-aminopyridine: new life for an old drug.
Ann Neurol. 2010 Jul;68(1):A8-9. doi: 10.1002/ana.22118.
Zotero 插件